466
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Progress in Multidisciplinary Treatment of Fournier’s Gangrene

, , ORCID Icon & ORCID Icon
Pages 6869-6880 | Received 15 Sep 2022, Accepted 10 Nov 2022, Published online: 28 Nov 2022

References

  • Shyam DC, Rapsang AG. Fournier’s gangrene. Surgeon. 2013;11(4):222–232. doi:10.1016/j.surge.2013.02.001
  • Fournier JA. Gangrene foudroyante de la verge. Semaine Medicale. 1883;3:345–348.
  • Wilson B. Necrotizing fasciitis. Am Surg. 1952;18(4):416–431.
  • Thwaini A, Khan A, Malik A, et al. Fournier’s gangrene and its emergency management. Postgrad Med J. 2006;82(970):516–519. doi:10.1136/pgmj.2005.042069
  • Sorensen MD, Krieger JN, Rivara FP, et al. Fournier’s Gangrene: population based epidemiology and outcomes. J Urol. 2009;181(5):2120–2126. doi:10.1016/j.juro.2009.01.034
  • Sorensen MD, Krieger JN. Fournier’s Gangrene: epidemiology and outcomes in the general US population. Urol Int. 2016;97(3):249–259. doi:10.1159/000445695
  • Eke N. Fournier’s gangrene: a review of 1726 cases. Br J Surg. 2000;87(6):718–728. doi:10.1046/j.1365-2168.2000.01497.x
  • Furr J, Watts T, Street R, et al. Contemporary trends in the inpatient management of Fournier’s Gangrene: predictors of length of stay and mortality based on population-based sample. Urology. 2017;102:79–84. doi:10.1016/j.urology.2016.09.021
  • Beecroft NJ, Jaeger CD, Rose JR, et al. Fournier’s Gangrene in females: presentation and management at a tertiary center. Urology. 2021;151:113–117. doi:10.1016/j.urology.2020.05.056
  • Ballard DH, Raptis CA, Guerra J, et al. Preoperative CT findings and interobserver reliability of Fournier Gangrene. AJR Am J Roentgenol. 2018;211(5):1051–1057. doi:10.2214/AJR.18.19683
  • Ugwumba FO, Nnabugwu I, Ozoemena OF. Fournier’s gangrene – analysis of management and outcome in south-eastern Nigeria. S Afr J Surg. 2012;50(1):16–19.
  • Radcliffe RS, Khan MA. Mortality associated with Fournier’s gangrene remains unchanged over 25 years. BJU Int. 2020;125(4):610–616. doi:10.1111/bju.14998
  • Bowen D, Juliebø-Jones P, Somani BK. Global outcomes and lessons learned in the management of Fournier’s gangrene from high-volume centres: findings from a literature review over the last two decades. World J Urol. 2022;40(10):2399–2410. doi:10.1007/s00345-022-04139-4
  • Yilmaz Baser H, Zumrutbas AE, Yilmaz A, et al. Importance of emergency department waiting period in Fournier’s Gangrene; 10 years of experience. Int J Clin Pract. 2021;75(9):e14361. doi:10.1111/ijcp.14361
  • Goh T, Goh LG, Ang CH, et al. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101(1):e119–e125. doi:10.1002/bjs.9371
  • El-Qushayri AE, Khalaf KM, Dahy A, et al. Fournier’s gangrene mortality: a 17-year systematic review and meta-analysis. Int J Infect Dis. 2020;92:218–225. doi:10.1016/j.ijid.2019.12.030
  • Laor E, Palmer LS, Tolia BM, et al. Outcome prediction in patients with Fournier’s gangrene. J Urol. 1995;154(1):89–92. doi:10.1016/S0022-5347(01)67236-7
  • Bozkurt O, Sen V, Demir O, et al. Evaluation of the utility of different scoring systems (FGSI, LRINEC and NLR) in the management of Fournier’s gangrene. Int Urol Nephrol. 2015;47(2):243–248. doi:10.1007/s11255-014-0897-5
  • Elsaket AE, Maharajh S, Urry RJ. The presentation, management and outcomes of Fournier’s gangrene at a tertiary urology referral centre in South Africa. S Afr Med J. 2018;108(8):671–676. doi:10.7196/SAMJ.2018.v108i8.13100
  • Ghodoussipour SB, Gould D, Lifton J, et al. Surviving Fournier’s gangrene: multivariable analysis and a novel scoring system to predict length of stay. J Plast Reconstr Aesthet Surg. 2018;71(5):712–718. doi:10.1016/j.bjps.2017.12.005
  • Vick R, Carson CC. Fournier’s disease. Urol Clin North Am. 1999;26(4):841–849. doi:10.1016/S0094-0143(05)70224-X
  • Smith GL, Bunker CB, Dinneen MD. Fournier’s gangrene. Br J Urol. 1998;81(3):347–355. doi:10.1046/j.1464-410x.1998.00532.x
  • Esposito S, Bassetti M, Concia E, et al. Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update. J Chemother. 2017;29(4):197–214. doi:10.1080/1120009X.2017.1311398
  • Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2018;378(10):971. doi:10.1056/NEJMc1800049
  • Elliott D, Kufera JA, Myers RA. The microbiology of necrotizing soft tissue infections. Am J Surg. 2000;179(5):361–366. doi:10.1016/S0002-9610(00)00360-3
  • Goodell KH, Jordan MR, Graham R, et al. Rapidly advancing necrotizing fasciitis caused by Photobacterium (Vibrio) damsela: a hyperaggressive variant. Crit Care Med. 2004;32(1):278–281. doi:10.1097/01.CCM.0000104920.01254.82
  • Morgan MS. Diagnosis and management of necrotising fasciitis: a multiparametric approach. J Hosp Infect. 2010;75(4):249–257. doi:10.1016/j.jhin.2010.01.028
  • Garcia NM, Cai J. Aggressive Soft Tissue Infections. Surg Clin North Am. 2018;98(5):1097–1108. doi:10.1016/j.suc.2018.05.001
  • Tang LM, Su YJ, Lai YC. The evaluation of microbiology and prognosis of Fournier’s gangrene in past five years. Springerplus. 2015;4(1):14. doi:10.1186/s40064-014-0783-8
  • Castillejo Becerra CM, Jaeger CD, Rose JR, et al. Microorganisms and antibiogram patterns in Fournier’s Gangrene: contemporary experience from a single tertiary care center. J Urol. 2020;204(6):1249–1255. doi:10.1097/JU.0000000000001194
  • Thayer J, Mailey BA. Two-stage neoscrotum reconstruction using porcine bladder extracellular Matrix after Fournier’s Gangrene. Plast Reconstr Surg Glob Open. 2020;8(8):e3034. doi:10.1097/GOX.0000000000003034
  • El-Shazly M, Aziz M, Aboutaleb H, et al. Management of equivocal (early) Fournier’s gangrene. Ther Adv Urol. 2016;8(5):297–301. doi:10.1177/1756287216655673
  • Sarkis P, Farran F, Khoury R, et al. Gangrène de Fournier : revue de la littérature récente[Fournier’s gangrene: a review of the recent literature]. Prog Urol. 2009;19(2):75–84. French. doi:10.1016/j.purol.2008.09.050
  • Xiu F, Stanojcic M, Diao L, et al. Stress hyperglycemia, insulin treatment, and innate immune cells. Int J Endocrinol. 2014;2014:486403. doi:10.1155/2014/486403
  • Trevelin SC, Carlos D, Beretta M, et al. Diabetes mellitus and sepsis: a challenging association. Shock. 2017;47(3):276–287. doi:10.1097/SHK.0000000000000778
  • Hatanaka E, Monteagudo PT, Marrocos MS, et al. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol. 2006;146(3):443–447. doi:10.1111/j.1365-2249.2006.03229.x
  • Voelzke BB, Hagedorn JC. Presentation and Diagnosis of Fournier Gangrene. Urology. 2018;114:8–13. doi:10.1016/j.urology.2017.10.031
  • Martinschek A, Evers B, Lampl L, et al. Prognostic aspects, survival rate, and predisposing risk factors in patients with Fournier’s gangrene and necrotizing soft tissue infections: evaluation of clinical outcome of 55 patients. Urol Int. 2012;89(2):173–179. doi:10.1159/000339161
  • Ferretti M, Saji AA, Phillips J. Fournier’s Gangrene: a review and outcome comparison from 2009 to 2016. Adv Wound Care. 2017;6(9):289–295. doi:10.1089/wound.2017.0730
  • Hatipoglu E, Demiryas S, Şimşek O, et al. Fournier’s gangrene: five years’ experience from a single center in Turkey. Ulus Travma Acil Cerrahi Derg. 2020;26(2):235–241. doi:10.14744/tjtes.2020.66805
  • David R, Traeger L, Kahokehr A, et al. A prospective case series of Fournier’s gangrene at a tertiary centre involving adjacent organs. ANZ J Surg. 2021;91(12):2817–2823. doi:10.1111/ans.17005
  • Montrief T, Long B, Koyfman A, et al. Fournier Gangrene: a review for emergency clinicians. J Emerg Med. 2019;57(4):488–500. doi:10.1016/j.jemermed.2019.06.023
  • Herrera Ortiz AF, Arámbula JG, Del Castillo V, et al. Fournier’s Gangrene with retroperitoneal extension as the first manifestation of the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS). Cureus. 2021;13(12):e20517. doi:10.7759/cureus.20517
  • Çalışkan S, Özsoy E, Sungur M, et al. Fournier’s gangrene: review of 36 cases. Ulus Travma Acil Cerrahi Derg. 2019;25(5):479–483. doi:10.14744/tjtes.2019.30232
  • Koyama M, Kitazawa M, Ehara T, et al. 直腸癌に対する化学療法中に発症した会陰部壊疽性筋膜炎の2 例 [Two cases of Fournier’s gangrene that occurred during chemotherapy for rectal cancer]. Gan To Kagaku Ryoho. 2017;44(2):169–171. Japanese.
  • Imamura S, Ogura N, Aoki Y, et al. 二次治療IRIS+Bevacizumab 投与中にフルニエ壊疽を発症した直腸肛門管癌の1 例 [A case of Fournier’s gangrene during second-line IRIS plus bevacizumab chemotherapy for rectal and anal canal cancer]. Gan To Kagaku Ryoho. 2022;49(5):597–599. Japanese.
  • Joury A, Mahendra A, Alshehri M, et al. Extensive necrotizing fasciitis from Fournier’s gangrene. Urol Case Rep. 2019;26:100943. doi:10.1016/j.eucr.2019.100943
  • García-García A, Galeano-Valle F, Nuevo-González JA, et al. Fournier’s gangrene and SGLT2 inhibitors: a case study. Endocrinol Diabetes Nutr. 2020;67(6):423–425. doi:10.1016/j.endinu.2019.12.007
  • Bersoff-Matcha SJ, Chamberlain C, Cao C, et al. Fournier Gangrene associated with sodium-glucose cotransporter-2 inhibitors: a review of spontaneous postmarketing cases. Ann Intern Med. 2019;170(11):764–769. doi:10.7326/M19-0085
  • Taylor L, Asmar O, Mandal A, et al. Perspectives from a regional plastic surgery centre on evidence for the purported link between SGLT2 inhibitors and Fournier’s Gangrene. Front Surg. 2021;8:754101. doi:10.3389/fsurg.2021.754101
  • Duarte I, Outerelo C, Santana A, et al. Fournier Gangrene as a complication of a perinephric abscess after kidney transplant: a case report. Transplant Proc. 2021;53(4):1281–1283. doi:10.1016/j.transproceed.2021.02.009
  • Santucci RA, Joyce GF, Wise M. Male urethral stricture disease. J Urol. 2007;177(5):1667–1674. doi:10.1016/j.juro.2007.01.041
  • Fialkov JM, Watkins K, Fallon B, et al. Fournier’s gangrene with an unusual urologic etiology. Urology. 1998;52(2):324–327. doi:10.1016/S0090-4295(98)00195-2
  • Mundy AR, Andrich DE. Urethral strictures. BJU Int. 2011;107(1):6–26. doi:10.1111/j.1464-410X.2010.09800.x
  • Louro JM, Albano M, Baltazar J, et al. Fournier’s Gangrene: 10-year experience of a plastic surgery and burns department at a tertiary hospital. Acta Med Port. 2019;32(5):368–374. doi:10.20344/amp.11003
  • Yücel M, Özpek A, Başak F, et al. Fournier’s gangrene: a retrospective analysis of 25 patients. Ulus Travma Acil Cerrahi Derg. 2017;23(5):400–404. doi:10.5505/tjtes.2017.01678
  • Numoto S, Kurahashi H, Azuma Y, et al. Fournier’s gangrene during ACTH therapy. Brain Dev. 2017;39(5):435–438. doi:10.1016/j.braindev.2016.11.012
  • Ameh EA, Dauda MM, Sabiu L, et al. Fournier’s gangrene in neonates and infants. Eur J Pediatr Surg. 2004;14(6):418–421. doi:10.1055/s-2004-821138
  • Fukui K, Fujioka M, Ishiyama S. Sacral pressure ulcer-induced Fournier’s Gangrene extending to the retroperitoneum: a case report. Wounds. 2018;30(1):E5–E8.
  • Zakariya-Yousef Breval I, Trujillo Díaz N, De La Herranz Guerrero P. [Fournier’s gangrene secondary to inguinoperineal abscess caused by Acidaminococcus intestini and Streptococcus gallolyticus spp. pasteurianus]. Rev Esp Quimioter. 2021;34(6):679–681. Spanish. doi:10.37201/req/070.2021
  • Sihombing AT, Palgunadi IN, Stefanus D. Complete urethral disruption as a complication of urethral catheterization presenting as scrotal mass: a rare case. Urol Case Rep. 2020;33:101378. doi:10.1016/j.eucr.2020.101378
  • López Pacios JC, Sánchez Merino JM, Piñeiro Fernández MC, et al. Gangrena de Fournier secundaria a cateterismo uretral [Fournier’s gangrene secondary to urethral catheterization]. Arch Esp Urol. 2005;58(2):167–170. Spanish. doi:10.4321/s0004-06142005000200012
  • Kumagai A, Ogawa D, Koyama T, et al. 経直腸的前立腺生検後にフルニエ壊疽を発症した管理不良な糖尿病患者の1例 [A case report of Fournier’s gangrene in a diabetic patient induced by transrectal prostate biopsy (TRPB)]. Nihon Hinyokika Gakkai Zasshi. 2002;93(5):648–651. Japanese. doi:10.5980/jpnjurol1989.93.648
  • Zingaro MD, Boni A, Vermandois JAR, et al. Fournier’s Gangrene and intravenous drug abuse: an unusual case report and review of the literature. Open Med. 2019;14:694–710. doi:10.1515/med-2019-0114
  • Ghazanfar H, Espinosa PV, Zeana C, et al. Penile necrosis associated with local intravenous injection of cocaine. Am J Case Rep. 2022;23:e935250. doi:10.12659/AJCR.935250
  • Ferreira PC, Reis JC, Amarante JM, et al. Fournier’s gangrene: a review of 43 reconstructive cases. Plast Reconstr Surg. 2007;119(1):175–184. doi:10.1097/01.prs.0000244925.80290.57
  • Erickson BA, Miller AC, Warner HL, et al. Understanding the prodrome of necrotizing soft tissue infections of the genitalia (Fournier’s Gangrene) and the incidence, duration, and risk factors associated with potential missed opportunities for an earlier diagnosis: a population-based longitudinal study. J Urol. 2022;25:10–97.
  • Lahouar R, Naouar S, Ben Khalifa B, et al. Isolated Penile Fournier’s gangrene: a very rare entity. Urol Case Rep. 2021;37:101608.
  • Abass-Shereef J, Kovacs M, Simon EL. Fournier’s Gangrene masking as perineal and scrotal cellulitis. Am J Emerg Med. 2018;36(9):1719.e1–1719.e2. doi:10.1016/j.ajem.2018.05.067
  • Singh A, Ahmed K, Aydin A, et al. Fournier’s gangrene. A clinical review. Arch Ital Urol Androl. 2016;88(3):157–164. doi:10.4081/aiua.2016.3.157
  • Moussa M, Abou Chakra M. Isolated Penile Fournier’s gangrene: a case report and literature review. Int J Surg Case Rep. 2019;62:65–68. doi:10.1016/j.ijscr.2019.08.012
  • Fernando SM, Tran A, Cheng W, et al. Necrotizing soft tissue infection: diagnostic accuracy of physical examination, imaging, and LRINEC score: a systematic review and meta-analysis. Ann Surg. 2019;269(1):58–65. doi:10.1097/SLA.0000000000002774
  • Zacharias N, Velmahos GC, Salama A, et al. Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg. 2010;145(5):452–455. doi:10.1001/archsurg.2010.50
  • Ballard DH, Mazaheri P, Raptis CA, et al. Fournier Gangrene in men and women: appearance on CT, Ultrasound, and MRI and what the surgeon wants to know. Can Assoc Radiol J. 2020;71(1):30–39. doi:10.1177/0846537119888396
  • Mcgillicuddy EA, Lischuk AW, Schuster KM, et al. Development of a computed tomography-based scoring system for necrotizing soft-tissue infections. J Trauma. 2011;70(4):894–899. doi:10.1097/TA.0b013e3182134a76
  • Yoneda A, Fujita F, Tokai H, et al. MRI can determine the adequate area for debridement in the case of Fournier’s gangrene. Int Surg. 2010;95(1):76–79.
  • Sweet DE, Feldman MK, Remer EM. Imaging of the acute scrotum: keys to a rapid diagnosis of acute scrotal disorders. Abdom Radiol. 2020;45(7):2063–2081. doi:10.1007/s00261-019-02333-4
  • Lee PC, Turnidge J, Mcdonald PJ. Fine-needle aspiration biopsy in diagnosis of soft tissue infections. J Clin Microbiol. 1985;22(1):80–83. doi:10.1128/jcm.22.1.80-83.1985
  • Avery LL, Scheinfeld MH. Imaging of penile and scrotal emergencies. Radiographics. 2013;33(3):721–740. doi:10.1148/rg.333125158
  • Auerbach J, Bornstein K, Ramzy M, et al. Fournier Gangrene in the emergency department: diagnostic dilemmas, treatments and current perspectives. Open Access Emerg Med. 2020;12:353–364. doi:10.2147/OAEM.S238699
  • Johnson LJ, Crisologo PA, Sivaganesan S, et al. Evaluation of the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score for detecting necrotizing soft tissue infections in patients with diabetes and lower extremity infection. Diabetes Res Clin Pract. 2021;171:108520. doi:10.1016/j.diabres.2020.108520
  • Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–1541.
  • Abdullah M, Mcwilliams B, Khan SU. Reliability of the Laboratory Risk Indicator in Necrotising Fasciitis (LRINEC) score. Surgeon. 2019;17(5):309–318.
  • García-Tarriño R, Ballesteros-Betancourt J, Soriano-Viladomiu A, et al. Necrotizing fasciitis: usefulness of the LRINEC score in a third-level hospital. Injury. 2021;52(Suppl 4):S8–S15.
  • Van Stigt S, Knubben M, Schrooten T, et al. Prognostic factors for mortality in 123 severe cases of necrotizing fasciitis in 5 hospitals in the Netherlands between 2003 and 2017. Eur J Trauma Emerg Surg. 2022;48(2):1189–1195.
  • Bakker J, Kattan E, Annane D, et al. Current practice and evolving concepts in septic shock resuscitation. Intensive Care Med. 2022;48(2):148–163.
  • Berlin DA, Bakker J. Understanding venous return. Intensive Care Med. 2014;40(10):1564–1566.
  • Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247.
  • Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010;36(2):222–231.
  • Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017;45(3):486–552.
  • Nawijn F, Smeeing DPJ, Houwert RM, et al. Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis. World J Emerg Surg. 2020;15:4.
  • Kabay S, Yucel M, Yaylak F, et al. The clinical features of Fournier’s gangrene and the predictivity of the Fournier’s Gangrene Severity Index on the outcomes. Int Urol Nephrol. 2008;40(4):997–1004.
  • Perry TL, Kranker LM, Mobley EE, et al. Outcomes in Fournier’s Gangrene using skin and soft tissue sparing flap preservation surgery for wound closure: an alternative approach to wide radical debridement. Wounds. 2018;30(10):290–299.
  • Hagedorn JC, Wessells H. A contemporary update on Fournier’s gangrene. Nat Rev Urol. 2017;14(4):205–214.
  • Erickson BA, Flynn KJ. Management of necrotizing soft tissue infections (Fournier’s Gangrene) and surgical reconstruction of debridement wound defects. Urol Clin North Am. 2022;49(3):467–478.
  • Chawla SN, Gallop C, Mydlo JH. Fournier’s Gangrene: an analysis of repeated surgical debridement. Eur Urol. 2003;43(5):572–575.
  • Tarasconi A, Perrone G, Davies J, et al. Anorectal emergencies: WSES-AAST guidelines. World J Emerg Surg. 2021;16(1):48.
  • Urbina T, Razazi K, Ourghanlian C, et al. Antibiotics in necrotizing soft tissue infections. Antibiotics. 2021;10(9):1104.
  • Arulkumaran N, Routledge M, Schlebusch S, et al. Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Med. 2020;46(2):225–235.
  • Tutino R, Colli F, Rizzo G, et al. Which role for hyperbaric oxygen therapy in the treatment of Fournier’s Gangrene? A retrospective study. Front Surg. 2022;9:850378.
  • Tanaka T, Minami A, Uchida J, et al. Potential of hyperbaric oxygen in urological diseases. Int J Urol. 2019;26(9):860–867.
  • Raizandha MA, Hidayatullah F, Kloping YP, et al. The role of hyperbaric oxygen therapy in Fournier’s Gangrene: a systematic review and meta-analysis of observational studies. Int Braz J Urol. 2022;48(5):771–781.
  • Schneidewind L, Anheuser P, Schönburg S, et al. Hyperbaric oxygenation in the treatment of Fournier’s gangrene: a systematic review. Urol Int. 2021;105(3–4):247–256.
  • Creta M, Longo N, Arcaniolo D, et al. Hyperbaric oxygen therapy reduces mortality in patients with Fournier’s Gangrene. Results from a multi-institutional observational study. Minerva Urol Nefrol. 2020;72(2):223–228.
  • Syllaios A, Davakis S, Karydakis L, et al. Treatment of Fournier’s Gangrene with vacuum-assisted closure therapy as enhanced recovery treatment modality. In Vivo. 2020;34(3):1499–1502.
  • Silberstein J, Grabowski J, Parsons JK. Use of a vacuum-assisted device for Fournier’s gangrene: a new paradigm. Rev Urol. 2008;10(1):76–80.
  • Iacovelli V, Cipriani C, Sandri M, et al. The role of vacuum-assisted closure (VAC) therapy in the management of FOURNIER’S gangrene: a retrospective multi-institutional cohort study. World J Urol. 2021;39(1):121–128.
  • Yanaral F, Balci C, Ozgor F, et al. Comparison of conventional dressings and vacuum-assisted closure in the wound therapy of Fournier’s gangrene. Arch Ital Urol Androl. 2017;89(3):208–211.
  • Czymek R, Schmidt A, Eckmann C, et al. Fournier’s gangrene: vacuum-assisted closure versus conventional dressings. Am J Surg. 2009;197(2):168–176.
  • Franco-Buenaventura D, Garcia-Perdomo HA. Vacuum-assisted closure device in the postoperative wound care for Fournier’s gangrene: a systematic review. Int Urol Nephrol. 2021;53(4):641–653.
  • Cipriani C, Iacovelli V, Sandri M, et al. The microbiological profile of patients with Fournier’s gangrene: a retrospective multi-institutional cohort study. Urologia. 2022;89(3):437–443.
  • Ozturk E, Sonmez Y, Yilmazlar T. What are the indications for a stoma in Fournier’s gangrene? Colorectal Dis. 2011;13(9):1044–1047.
  • Sarofim M, Di RA, Descallar J, et al. Relationship between diversional stoma and mortality rate in Fournier’s gangrene: a systematic review and meta-analysis. Langenbecks Arch Surg. 2021;406(8):2581–2590.
  • Sherman KL, Wexner SD. Considerations in Stoma Reversal. Clin Colon Rectal Surg. 2017;30(3):172–177.
  • Li YD, Zhu WF, Qiao JJ, et al. Enterostomy can decrease the mortality of patients with Fournier gangrene. World J Gastroenterol. 2014;20(24):7950–7954.
  • Padmanabhan A, Stern M, Wishin J, et al. Clinical evaluation of a flexible fecal incontinence management system. Am J Crit Care. 2007;16(4):384–393.
  • Goh M, Chew MH, Au-Yong PS, et al. Nonsurgical faecal diversion in the management of severe perianal sepsis: a retrospective evaluation of the flexible faecal management system. Singapore Med J. 2014;55(12):635–639.
  • Page BP, Boyce SA, Deans C, et al. Significant rectal bleeding as a complication of a fecal collecting device: report of a case. Dis Colon Rectum. 2008;51(9):1427–1429.
  • Kühbacher A, Burger-Kentischer A, Rupp S. Interaction of candida species with the skin. Microorganisms. 2017;5(2):32.
  • De Groot T, Janssen T, Faro D, et al. Antifungal activity of a medical-grade honey formulation against candida auris. J Fungi. 2021;7(1):50.
  • Sufya N, Matar N, Kaddura R, et al. Evaluation of bactericidal activity of Hannon honey on slowly growing bacteria in the chemostat. Drug Healthc Patient Saf. 2014;6:139–144.
  • Sandberg JM, Warner HL, Flynn KJ, et al. Favorable outcomes with early component separation, primary closure of necrotizing soft tissue infections of the genitalia (Fournier’s Gangrene) debridement wound defects. Urology. 2022;166:250–256.
  • Insua-Pereira I, Ferreira PC, Teixeira S, et al. Fournier’s gangrene: a review of reconstructive options. Cent European J Urol. 2020;73(1):74–79.
  • Karian LS, Chung SY, Lee ES. Reconstruction of defects after Fournier gangrene: a systematic review. Eplasty. 2015;15:e18.
  • Michael P, Peiris B, Ralph D, et al. Genital reconstruction following Fournier’s Gangrene. Sex Med Rev. 2022;10(4):800–812.